Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Moviprep. Always confirm against the full prescribing information.
100 interactions
Acebutolol
Potassium chloride may increase the hyperkalemic activities of Acebutolol.
Level 2 evidence
Aceclofenac
Potassium chloride may increase the hyperkalemic activities of Aceclofenac.
Level 2 evidence
Acetazolamide
The risk or severity of dehydration can be increased when Acetazolamide is combined with Sodium ascorbate.
Level 2 evidence
Acetazolamide
The risk or severity of dehydration can be increased when Acetazolamide is combined with Sodium sulfate.
Level 2 evidence
Acetazolamide
The risk or severity of dehydration can be increased when Acetazolamide is combined with Polyethylene glycol.
Level 2 evidence
Acetylsalicylic acid
Potassium chloride may increase the hyperkalemic activities of Acetylsalicylic acid.
Level 2 evidence
Aliskiren
Potassium chloride may increase the hyperkalemic activities of Aliskiren.
Level 2 evidence
Aluminum hydroxide
Ascorbic acid can cause an increase in the absorption of Aluminum hydroxide resulting in an increased serum concentration and potentially a worsening of adverse effects.
Level 1 evidence
Amikacin
Sodium sulfate may decrease the excretion rate of Amikacin which could result in a higher serum level.
Level 2 evidence
Amikacin
Potassium chloride may decrease the excretion rate of Amikacin which could result in a higher serum level.
Level 2 evidence
Amiloride
The risk or severity of dehydration can be increased when Amiloride is combined with Sodium sulfate.
Level 2 evidence
Amiloride
The risk or severity of dehydration can be increased when Amiloride is combined with Polyethylene glycol.
Level 2 evidence
Amiloride
The risk or severity of dehydration can be increased when Amiloride is combined with Sodium ascorbate.
Level 2 evidence
Enter your NPI to unlock 1 major interaction for Moviprep
Moviprep (Polyethylene Glycol 3350, Sodium Sulfate, Sodium Chloride, Potassium Chloride, Ascorbic Acid, Sodium Ascorbate) has 1626 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Moviprep (Polyethylene Glycol 3350, Sodium Sulfate, Sodium Chloride, Potassium Chloride, Ascorbic Acid, Sodium Ascorbate) has 10 major, 278 moderate, and 1338 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Moviprep. Always confirm against the full prescribing information.